Qualigen Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QLGN and other ETFs, options, and stocks.

About QLGN

Qualigen Therapeutics, Inc. is a biotechnology company focused on developing therapeutics for the treatment of cancer and infectious diseases. The company's cancer therapeutics pipeline includes ALAN (AS1411-GNP), RAS-F3 and STARS.

CEO

Kevin A. Richardson

CEOKevin A. Richardson

Employees

—

Employees—

Headquarters

Carlsbad, California

HeadquartersCarlsbad, California

Founded

2004

Founded2004

Employees

—

Employees—

QLGN Key Statistics

Market cap

2.88M

Market cap2.88M

Price-Earnings ratio

-0.10

Price-Earnings ratio-0.10

Dividend yield

—

Dividend yield—

Average volume

139.51K

Average volume139.51K

High today

$1.92

High today$1.92

Low today

$1.72

Low today$1.72

Open price

$1.90

Open price$1.90

Volume

83.66K

Volume83.66K

52 Week high

$11.50

52 Week high$11.50

52 Week low

$1.72

52 Week low$1.72

People also own

Based on the portfolios of people who own QLGN. This list is generated using Robinhood data, and it’s not a recommendation.